clopidogrel by chewing — Competitive Intelligence Brief

clopidogrel by chewing (clopidogrel by chewing) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: antiplatelet. Area: Cardiovascular.

phase 3 antiplatelet P2Y12 receptor Cardiovascular Small molecule

Target snapshot

clopidogrel by chewing (clopidogrel by chewing) — Sheba Medical Center. Clopidogrel inhibits platelet activation and aggregation by irreversibly inhibiting the P2Y12 receptor.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
clopidogrel by chewing TARGET	clopidogrel by chewing	Sheba Medical Center	phase 3	antiplatelet	P2Y12 receptor
Switch ticagrelor to clopidogrel	Switch ticagrelor to clopidogrel	The First Affiliated Hospital with Nanjing Medical University	marketed	P2Y12 receptor antagonist; antiplatelet agent	P2Y12 receptor
aspirin and/or clopidogrel	aspirin and/or clopidogrel	Asan Medical Center	marketed	Antiplatelet agent	COX (aspirin); P2Y12 receptor (clopidogrel)
Blinded clopidogrel	Blinded clopidogrel	VA Office of Research and Development	marketed	Antiplatelet agents	P2Y12 receptor
Aspirin and thienopyridine	Aspirin and thienopyridine	Associations for Establishment of Evidence in Interventions	marketed	Dual antiplatelet agent combination	COX-1 (aspirin); P2Y12 receptor (thienopyridine)
Clopidogrel treatment	Clopidogrel treatment	VA Office of Research and Development	marketed	P2Y12 receptor antagonist / Thienopyridine antiplatelet agent	P2Y12 receptor
Beta blocker, aspirin, clopidogrel	Beta blocker, aspirin, clopidogrel	Spanish Society of Cardiology	marketed	Combination antithrombotic and antihypertensive therapy	Beta-adrenergic receptors; COX-1; P2Y12 receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (antiplatelet class)

1. Beijing Tiantan Hospital · 1 drug in this class
2. Catholic University of the Sacred Heart · 1 drug in this class
3. Icahn School of Medicine at Mount Sinai · 1 drug in this class
4. NYU Langone Health · 1 drug in this class
5. Samsung Medical Center · 1 drug in this class
6. Sheba Medical Center · 1 drug in this class
7. Sichuan Provincial People's Hospital · 1 drug in this class
8. University of Athens · 1 drug in this class